PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function

A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS

2014-02-05
(Press-News.org) Contact information: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS (MEMPHIS, Tenn. – February 5, 2014) St. Jude Children's Research Hospital scientists led a study showing that mutations in a gene responsible for amyotrophic lateral sclerosis (ALS) disrupt the RNA transport system in nerve cells. The findings appear in the current issue of the scientific journal Neuron and offer a new focus for efforts to develop effective treatments.

The findings offer a new avenue for researchers to pursue in the quest for desperately needed treatments for ALS, a disorder that kills most patients within five years of diagnosis. ALS, also known as Lou Gehrig's disease, is diagnosed in about 5,600 individuals nationwide each year and is associated with muscle weakness and paralysis.

The gene, TDP-43, carries instructions for making a protein of the same name. While mutations in TDP-43 were known to cause ALS and a related neurodegenerative disorder, until now the mechanism involved was a mystery. This study showed for the first time that the mutations disrupt efficient movement within nerve cells of RNA molecules. These RNA molecules direct protein assembly based on instructions carried in DNA. Correct transport of these RNAs permits proteins to be made in the right place at the right time.

Working in motor neurons derived from patients with ALS, researchers demonstrated that each of three different TDP-43 mutations impaired delivery of RNA molecules to their final destination near the junction where a nerve and its target muscle meet. Without the RNA molecules, nerves cannot make proteins necessary to function normally and respond quickly when stimulated. Motor neurons govern movement, including breathing. Their death and deterioration is a hallmark of ALS.

The results also provide insight into how problems in RNA metabolism, including disturbances in RNA regulation and functioning, lead to ALS and other neurodegenerative diseases.

"Five years of tremendous progress in ALS genetics has revealed that RNA metabolism is a critical pathway that is impaired in this disease," said the study's corresponding author J. Paul Taylor, M.D., Ph.D., a member of the St. Jude Department of Developmental Neurobiology. "But RNA metabolism is a complex process that involves multiple steps that are carried out in different parts of the cell. This study provides a more refined understanding of how ALS-causing mutations impair RNA metabolism so we know what needs fixing therapeutically."

TDP-43 belongs to a family of proteins that bind to RNA and regulate its function. Normally TDP-43 is stored in the cell's command center, the nucleus. There the protein prepares DNA for translation into the proteins that do the work of cells and shuttles the resulting RNA, called mRNA, from the nucleus to the cytoplasm, the cell's liquid center. While clumps of TDP-43 were known to accumulate in the cytoplasm of the motor neurons of patients with ALS and other neurodegenerative diseases, the protein's function there was unknown.

This study provides an answer. The work was done in motor neurons from the fruit fly Drosophila melanogaster, mouse brain cells and human motor neurons produced by reprogramming cells from ALS patients with three different TDP-43 mutations. Co-first author Nael Alami, Ph.D., a postdoctoral fellow in Taylor's laboratory, developed a florescent RNA beacon that let investigators track movement of RNA molecules in living cells.

Researchers demonstrated that TDP-43 is part of a molecule called an RNA transport granule. These granules are responsible for moving mRNA efficiently to the end of the axon where the molecule is translated into a protein. For this study, scientists used Neurofilament-L (NEFL) mRNA, which is known to bind TDP-43.

In human motor neurons growing in the laboratory, investigators found that transport granules with mutant TDP-43 were more likely than granules with unaltered TDP-43 to stall en route to the nerve ending and sometimes reverse direction. The defect in the human ALS motor neurons was apparent after the first week.

Evidence from mice suggests TDP-43 mutations selectively rather than globally disrupt movement in nerve cells. The mutations did not affect movement of another cell structure, the mitochondria, along the axon where mRNA movement was impaired.

"We know neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, seem to share a common mechanism," Alami said. "We plan to use our finding from this study to look for similar defects in those diseases."

### Rebecca Smith, Ph.D., formerly of St. Jude, is co-first author of the study. The other authors are Monica Carrasco and Tom Maniatis, both of Columbia University Medical Center, New York; Luis Williams, Steve Han, Evangelos Kiskinis and Kevin Eggan, all of Harvard University, Cambridge, Mass.; Christina Winborn and Edward Chaum, both of the University of Tennessee Health Science Center, Memphis; Brett Winborn, Brian Freibaum, Anderson Kanagaraj and Nisha Badders, all of St. Jude; Alison Clare, formerly of St. Jude; Bilada Bilican and Siddharthan Chandran, University of Edinburgh, United Kingdom; and Christopher Shaw, King's College London.

The research was funded in part by the Packard Foundation, the Muscular Dystrophy Association; the ALS Association, grants (NS053825 and AG031587) from the National Institutes of Health, a grant (CA021765-34) from the National Cancer Institute, which is part of NIH, and ALSAC.

St. Jude Media Relations Contacts

Carrie Strehlau
desk: (901) 595-2295
cell: (901) 297-9875
carrie.strehlau@stjude.org

Summer Freeman
desk: (901) 595-3061
cell: (901) 297-9861
summer.freeman@stjude.org


ELSE PRESS RELEASES FROM THIS DATE:

Pinpointing the brain's arbitrator

2014-02-05
We tend to be creatures of habit. In fact, the human brain has a learning system that is devoted to guiding us through routine, or habitual, ...

Study untangles divergent US job-tenure patterns

2014-02-05
WASHINGTON, DC, February 5, 2014 — Have American jobs become less stable? Do workers change ...

Predicting cardiovascular events in sleep apnea

2014-02-05
Obstructive sleep apnea (OSA) generally is associated with increased risk for cardiovascular (CV) disease. OSA is usually measured using the apnea-hypopnea index (AHI), the number of times that breathing pauses or severely slows per hour of sleep. ...

Educational toolkit did not improve quality of care or outcomes for patients with diabetes

2014-02-05
An educational toolkit designed to improve care of patients with diabetes was not effective, Baiju R Shah and colleagues (University of Toronto) found in a cluster randomized trial conducted in 2009-2011. ...

Pattern of higher blood pressure in early adulthood helps predict risk of heart disease

2014-02-05
In an analysis of blood pressure patterns over a 25-year span from young adulthood to middle age, individuals who exhibited elevated and increasing blood pressure levels ...

Study shows potential usefulness of non-invasive measure of heart tissue scarring

2014-02-05
Scarring of tissue in the upper chamber of the heart (atrium) was associated with recurrent rhythm disorder after treatment, according to a study in the February 5 issue of JAMA. ...

Pre-term infants with severe retinopathy more likely to have non-visual disabilities

2014-02-05
In a group of very low-birth-weight infants, severe retinopathy of prematurity was associated with nonvisual disabilities at age 5 years, according to a study in the February ...

Do you have a sweet tooth? Honeybees have a sweet claw

2014-02-05
New research on the ability of honeybees to taste with claws on their forelegs reveals details on how this information is processed, according to a study published in the open-access journal, Frontiers in Behavioral Neuroscience. Insects ...

Clearer labels needed on drugs containing animal products

2014-02-05
Dr Kinesh Patel and Dr Kate Tatham say most medications prescribed in primary care contain animal derived products and it ...

Is institutional racism happening in our hospitals?

2014-02-05
Dr Nadeem Moghal, from George Eliot Hospital in Warwickshire, draws on the Macpherson report (the police ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Mechanism discovered for how amyotrophic lateral sclerosis mutations damage nerve function
A study led by St. Jude Children's Research Hospital offers a new avenue for scientists to pursue in the quest for desperately needed treatments for ALS